IGF2BP1 and nasopharyngeal carcinoma: A recent study has shown that the risk signature composed of three m6A related genes (IGF2BP1 + IGF2BP2 + METTL3) was an independent prognostic factor and could predict the clinicopathological features of NPC (16).